VASOPRESSIN

N/A

Manufactured by Par Health USA, LLC

16,089 FDA adverse event reports analyzed

Last updated: 2026-04-15

About VASOPRESSIN

VASOPRESSIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Par Health USA, LLC. The most commonly reported adverse reactions for VASOPRESSIN include DRUG INEFFECTIVE, OFF LABEL USE, HYPOTENSION, CARDIOGENIC SHOCK, SEPSIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for VASOPRESSIN.

Top Adverse Reactions

DRUG INEFFECTIVE1,262 reports
OFF LABEL USE512 reports
HYPOTENSION486 reports
CARDIOGENIC SHOCK389 reports
SEPSIS380 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME375 reports
CONDITION AGGRAVATED359 reports
TOXICITY TO VARIOUS AGENTS317 reports
ACUTE KIDNEY INJURY308 reports
STRESS289 reports
VOMITING289 reports
ABDOMINAL PAIN263 reports
HYPONATRAEMIA260 reports
GENERAL PHYSICAL HEALTH DETERIORATION259 reports
NAUSEA256 reports
ASCITES255 reports
ABDOMINAL DISTENSION250 reports
CARDIAC ARREST246 reports
APPENDICITIS234 reports
APPENDICOLITH233 reports
CONSTIPATION232 reports
DEATH216 reports
INTENTIONAL OVERDOSE216 reports
RENAL FAILURE216 reports
VENTRICULAR FIBRILLATION211 reports
RESPIRATORY FAILURE185 reports
SHOCK182 reports
PRODUCT USE IN UNAPPROVED INDICATION177 reports
METABOLIC ACIDOSIS174 reports
SOMNOLENCE174 reports
LACTIC ACIDOSIS169 reports
SEPTIC SHOCK168 reports
OVERDOSE164 reports
ANAEMIA149 reports
DYSPNOEA144 reports
PAIN143 reports
PNEUMONIA142 reports
BLOOD PHOSPHORUS INCREASED138 reports
DRY MOUTH136 reports
PULMONARY EMBOLISM132 reports
BRADYCARDIA124 reports
TACHYCARDIA124 reports
INTENTIONAL PRODUCT MISUSE123 reports
ACUTE RESPIRATORY DISTRESS SYNDROME122 reports
BLOOD CHOLESTEROL INCREASED122 reports
DIABETES MELLITUS122 reports
BACTERIAL INFECTION121 reports
THROMBOSIS120 reports
MYASTHENIA GRAVIS119 reports
HYPOXIA116 reports
DRUG HYPERSENSITIVITY114 reports
RENAL IMPAIRMENT112 reports
INCORRECT ROUTE OF PRODUCT ADMINISTRATION111 reports
BLOOD URIC ACID INCREASED109 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION108 reports
DRUG INTOLERANCE108 reports
SWELLING108 reports
HYPERPHOSPHATAEMIA106 reports
INJURY106 reports
ANXIETY104 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE104 reports
HYPOPHOSPHATAEMIA104 reports
NEURALGIA104 reports
DRUG INTERACTION99 reports
UNEVALUABLE EVENT99 reports
SLEEP DISORDER97 reports
MULTI ORGAN FAILURE96 reports
BLOOD CREATININE INCREASED94 reports
FEAR91 reports
RENAL INJURY91 reports
ASPARTATE AMINOTRANSFERASE INCREASED89 reports
HYPERTENSION88 reports
IRON DEFICIENCY85 reports
VASOPLEGIA SYNDROME80 reports
RHABDOMYOLYSIS79 reports
EMOTIONAL DISTRESS78 reports
PYREXIA77 reports
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED75 reports
ANALGESIC THERAPY75 reports
PULMONARY OEDEMA74 reports
THROMBOCYTOPENIA73 reports
ANHEDONIA71 reports
END STAGE RENAL DISEASE71 reports
DRUG THERAPY70 reports
COMA69 reports
SLEEP DISORDER THERAPY69 reports
ATRIAL FIBRILLATION68 reports
DISTRIBUTIVE SHOCK68 reports
PLEURAL EFFUSION68 reports
HAEMODYNAMIC INSTABILITY67 reports
RENAL FAILURE ACUTE67 reports
DIABETES INSIPIDUS65 reports
GOUT64 reports
HYPERLIPIDAEMIA64 reports
HYPOGLYCAEMIA64 reports
OEDEMA PERIPHERAL62 reports
TROPONIN INCREASED62 reports
SUICIDE ATTEMPT61 reports
DISSEMINATED INTRAVASCULAR COAGULATION59 reports
ULCER59 reports

Report Outcomes

Out of 4,134 classified reports for VASOPRESSIN:

Serious 96.4%Non-Serious 3.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male2,168 (57.5%)
Female1,599 (42.4%)
Unknown5 (0.1%)

Reports by Age

Age 80290 reports
Age 6498 reports
Age 6394 reports
Age 5993 reports
Age 6888 reports
Age 6085 reports
Age 5581 reports
Age 6279 reports
Age 4966 reports
Age 5366 reports
Age 5765 reports
Age 6165 reports
Age 1564 reports
Age 6563 reports
Age 5160 reports
Age 6759 reports
Age 5857 reports
Age 4754 reports
Age 7454 reports
Age 4253 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with VASOPRESSIN?

This profile reflects 16,089 FDA FAERS reports that mention VASOPRESSIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for VASOPRESSIN?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, HYPOTENSION, CARDIOGENIC SHOCK, SEPSIS, MULTIPLE ORGAN DYSFUNCTION SYNDROME. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures VASOPRESSIN?

Labeling and FAERS entries often list Par Health USA, LLC in connection with VASOPRESSIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.